Stock Analysis
CTRE (CTRE) Stock Analysis
CTRE (CTRE) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
CTRE (CTRE) currently has an AIQ Score of 52/100, indicating a neutral setup. Quality is the strongest factor at 65/100. Value is the weakest current factor at 40/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
CTRE at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $36.39 |
| AIQ Score | 52/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Sell |
| Market Cap | $9.43B |
| P/E Ratio (TTM) | 24.8 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | $0.38 |
| Revenue (quarter ended 2026-06-30) | $161.35M |
| Dividend Yield (TTM) | 3.63% |
| Beta | 0.8 |
| Volume | 2.09M |
| 52-week range | $33.72-$43.62 |
| RSI 14 | 51.63 |
| 50-Day SMA | $37.60 |
| 200-Day SMA | $39.01 |
| Analyst Price Target | — |
| Next Earnings | — |
CTRE
Low Priority
Above Peers
Latest quote
- Momentum43
- Value40
- Quality65
- Risk resilience63
- Sentiment63
CTRE Stock Analysis Summary
CTRE (CTRE) currently has an AIQ Score of 52/100, indicating a neutral setup. Quality is the strongest factor at 65/100. Value is the weakest current factor at 40/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, CTRE has AIQ Score of 52/100 with Quality base of 65/100 and fading Value at 40/100. Wait for component alignment before adding exposure.
Quality (65/100) leads while Value (40/100) lags. This cross-factor spread creates entry timing uncertainty.
Sector · 0.36% stock move · CTRE classified in its covered industry.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is CTRE Bullish or Bearish Right Now?
CTRE currently has a neutral overall setup. Quality is the strongest factor at 65/100, while Value is weakest at 40/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 65/100.
- - Risk Resilience is supportive at 63/100.
- - Value is the current constraint at 40/100.
- - Momentum is weak at 43/100.
- - Price is -7.05% below its 200-day SMA.
- - Technical consensus has more sell votes than buy votes (24 vs 6).
Current Consensus
CTRE's Technical Analysis Consensus is currently Sell, with 6 buy, 15 neutral, and 24 sell votes. CTRE's 14-day RSI is 51.63, which places the stock in a neutral momentum range. CTRE's beta is 0.8, indicating lower market sensitivity than the broad market.
What Changed in CTRE?
The largest recent change in CTRE is Risk Resilience moving down by 2.0 points over the available 7-day comparison window. Quality remains the strongest visible factor.
What Would Change the CTRE Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
CTRE Decision Framework
Public evidence layers, setup checks, and risk context for CTRE.
CTRE (CTRE) Stock Analysis
CTRE has an AIQ Score of 52/100 in a Neutral regime. Quality is strongest at 65/100. Beta is not shown in the current snapshot. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | CTRE is in a Neutral AIQ regime with score 52/100. |
| Signal Conflict | The primary conflict is that quality leads at 65/100 while value lags at 40/100. |
| Factor Evidence | Momentum 43/100 · Value 40/100 · Quality 65/100 · Risk 63/100 · Sentiment 63/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Quality is the strongest factor at 65/100.
Momentum is 43/100 and RSI (14) is 51.6.
CTRE is in a Neutral regime at 52/100.
Risk factor is 63/100 and annual volatility 24.94%.
Current conflict: quality leads at 65/100 while value lags at 40/100.
CTRE Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
CTRE Fundamentals
CTRE valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
CTRE Technical Analysis
CTRE technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
CTRE Stock Catalysts
Track CTRE earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
CTRE Dividend Analysis
CTRE dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
CTRE Financial Data
CTRE revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
CTRE Risk Analysis
CTRE volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
CTRE Stock News
CTRE stock news, market tone, recent headlines, and catalyst context.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching CTRE
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for CTRE
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
CTRE Stock FAQ
What is CTRE stock price today?
CTRE's current stock price is $36.39. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is CTRE bullish or bearish right now?
CTRE's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is CTRE's market cap?
CTRE's market cap is $9.43B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is CTRE's current P/E ratio?
CTRE's current P/E ratio is 24.8 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is CTRE's RSI?
CTRE's 14-day RSI is 51.63 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is CTRE above its 50-day and 200-day moving averages?
CTRE is -3.55% from its 50-day SMA and -7.05% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is CTRE's next earnings date?
CTRE's next earnings date is a key event to check before making a decision. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does CTRE pay a dividend?
CTRE's dividend yield is 3.63% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.